RANBAXY Pharmaceuticals has
launched generic pioglitazone
hydrochloride tablets in the US
market, under an agreement with
Takeda Pharmaceuticals.
Pioglitazone hydrochloride tablets
are an oral antidiabetic agent that
acts to decrease insulin resistance.
MEANWHILE the US FDA has also
approved Reckitt Benckiser
Pharmaceuticals’ 4mg and 12mg
doses of Suboxone (buprenorphine
and naloxone) sublingual film,
which is indicated for maintenance
treatment of opioid dependence.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Aug 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Aug 12
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.